Sarepta (SRPT) COO Ian Estepan Shares Withheld for Taxes — 24,799

What Happened

• Ian Michael Estepan, Chief Operating Officer of Sarepta Therapeutics (SRPT), had 24,799 shares withheld by the company on September 4, 2026 to satisfy tax withholding obligations tied to vested restricted stock units. The withholding value was $551,034 at $22.22 per share. This is a tax-withholding disposition (Form 4 code F), not an open-market sale.

Key Details

• Transaction date and price: September 4, 2026 — 24,799 shares withheld at $22.22/share (total $551,034).
• Shares owned after transaction: Not specified in the excerpt of the filing.
• Footnote: Shares were withheld to satisfy tax withholding on RSUs granted September 3, 2025 (F1).
• Filing timeliness: Form 4 filed September 8, 2026 — appears timely (filed after the Labor Day holiday).

Context

• Code F indicates company withholding to cover tax liabilities for vested equity; this is effectively a cashless tax payment rather than a market sale and should not be read as a directional bet by the insider. Such withholdings are routine following RSU vesting.